MarginsXMarginsX
Home › Markets › Health Care › OMDA

Omada Health Inc. (OMDA)

OMDA trades on Nasdaq in Health Care, Medical/Nursing Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$14.49
+1.12% on the day
Market cap
$898.9M
Small cap
Revenue · 2025
$260.2M
+53.2% on 2024
Net income · 2025
-$12.8M
-4.9% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1611115/000162828026015637/0001628280-26-015637-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerOMDA on Nasdaq
SectorHealth Care
IndustryMedical/Nursing Services
CountryUnited States
IPO year2025
SEC CIK0001611115
SEC industry codeServices-Health Services
Incorporated inDE

Financials · 2025

LineValue
Revenue$260.2M
Net income-$12.8M
Operating income-$12.0M
Net margin-4.9%
Operating margin-4.6%
Revenue growth+53.2%
Cash$222.0M
Total assets$305.4M
P/E (computed)Net income was not positive
P/S (computed)3.5×

Warning signs

Cash runway
Cash-flow positive
$243.2M cash at September 30, 2026
Share count, 1 year
+7.1%
2025-11-05 to 2026-11-03
Going-concern doubt
No
10-Q filed November 6, 2026
Insider net buying, 12 months
-$11.9M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-06
Cash and burn$243.2M cash; operating cash flow $7.2M a quarter.Report 2026-09-30
Shares outstanding62,037,725 (2026-11-03); 57,908,047 a year earlier.Cover page 2026-11-03
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, San Francisco, California, United StatesPCAOB Form AP 2026-03-19
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $11.9M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$91.3M$6.6M$15.1M$243.2MNo debt tags$333.0M10-Q 2026-11-06
Q2 2026
2026-06-30
$87.8M$5.3M$4.0M$221.7MNo debt tags$309.8M10-Q 2026-08-07
Q1 2026
2026-03-31
$78.0M-$3.0M-$11.8M$211.8MNo debt tags$283.3M10-Q 2026-05-08
Q4 2025
2025-12-31
$75.8M$5.2M$21.4M$222.0M$0$260.2M10-K 2026-03-06
Q3 2025
2025-09-30
$68.0M-$3.2M$10.1M$198.6M$0$232.3M10-Q 2026-11-06
Q2 2025
2025-06-30
$61.4M-$5.3M$2.9M$223.1M$30.0M$209.8M10-Q 2026-08-07
Q1 2025
2025-03-31
$55.0M-$9.4M-$16.1M$59.4MNo debt tags$189.7M10-Q 2026-05-08
Q4 2024
2024-12-31
$48.0M-$8.3M-$6.5M$76.4M$29.8M$169.8M10-K 2026-03-06

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42025-06-09
Latest annual report10-K2026-03-06
Latest quarterly / interim10-Q2026-11-06
Latest current report8-K2026-11-05
Latest proxyDEFA14A2026-04-28

Source: SEC EDGAR submissions feed, 240 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-5.0%
1 month-21.7%
3 months-41.2%
Year to date-9.2%
1 year-31.0%
From 52-week high-42.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Nursing Services

TickerCompanyPriceDayMarket cap
AHCOAdaptHealth Corp.$7.73+0.91%$1.1B
SBCSBC Medical Group Holdings Incorporated$6.18-15.92%$635.6M
PNTGThe Pennant Group Inc. Common Stock$37.03+2.66%$1.3B
INNVInnovAge Holding Corp.$9.58+1.16%$1.3B
USPHU.S. Physical Therapy Inc.$99.55+0.41%$1.5B
WGSGeneDx Holdings Corp.$51.02-2.58%$1.5B
TDOCTeladoc Health Inc.$8.70-1.14%$1.6B
SRTAStrata Critical Medical Inc.$5.42-1.63%$484.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier